13787-59-2Relevant articles and documents
Evaluation of Cyclic Amides as Activating Groups in N-C Bond Cross-Coupling: Discovery of N-Acyl-δ-valerolactams as Effective Twisted Amide Precursors for Cross-Coupling Reactions
Bisz, Elwira,Chen, Hao,Dziuk, B?a?ej,Ejsmont, Krzysztof,Lalancette, Roger,Pyle, Daniel J.,Rahman, Md. Mahbubur,Szostak, Michal,Szostak, Roman,Wang, Qi
, p. 10455 - 10466 (2021/07/31)
The development of efficient methods for facilitating N-C(O) bond activation in amides is an important objective in organic synthesis that permits the manipulation of the traditionally unreactive amide bonds. Herein, we report a comparative evaluation of a series of cyclic amides as activating groups in amide N-C(O) bond cross-coupling. Evaluation of N-acyl-imides, N-acyl-lactams, and N-acyl-oxazolidinones bearing five- and six-membered rings using Pd(II)-NHC and Pd-phosphine systems reveals the relative reactivity order of N-activating groups in Suzuki-Miyaura cross-coupling. The reactivity of activated phenolic esters and thioesters is evaluated for comparison in O-C(O) and S-C(O) cross-coupling under the same reaction conditions. Most notably, the study reveals N-acyl-δ-valerolactams as a highly effective class of mono-N-acyl-activated amide precursors in cross-coupling. The X-ray structure of the model N-acyl-δ-valerolactam is characterized by an additive Winkler-Dunitz distortion parameter ?(τ+χN) of 54.0°, placing this amide in a medium distortion range of twisted amides. Computational studies provide insight into the structural and energetic parameters of the amide bond, including amidic resonance, N/O-protonation aptitude, and the rotational barrier around the N-C(O) axis. This class of N-acyl-lactams will be a valuable addition to the growing portfolio of amide electrophiles for cross-coupling reactions by acyl-metal intermediates.
Synthesis, spectroscopic characterization and antimicrobial activities of benzoxazolone derivatives
Siddiqui, Nida I.,Versiani, Muhammad A.,Jawaid, Khurshid,Shafique, Maryam,Hameed, Abdul,Ambreen, Nida,Karim, Aneela,Khan, Khalid M.
, p. 384 - 390 (2017/06/20)
Background: Pathogenic microbial diseases are now the key virulence in our daily life. Significant research has been carried out in order to trigger the bacterial infections. Amongst the organic molecules, oxazolone and derivatives were found to have excellent bioactivities including antimicrobial activities. Methods: By keeping in mind the considerable antimicrobial activities of class benzoxazolones, a series of benzoxazolone derivatives 3-16 have been synthesized. Out of which five compounds 10, 11, 14, 15, and 16 were new synthetic derivatives whereas compounds 9, 12, and 13 were already known compounds. These compounds have been synthesized by refluxing of amino phenol and 1,1-carbonyldiimidazole1 (CHN)CO) (CDI) in a dry THF and then treated with commercially available acid chloride. The structures of the compounds were elucidated on the basis of 1H-NMR, EIMS and elemental analysis. All the compounds were screened for their antibacterial activities and tested by agar well diffusion method. Results: Compounds 14 and 16 showed good activity against S. aureus. Compound 5 showed good while 14 and 16 were found to be most active against E. coli using cefuroxime as a standard. Antifungal activities were carried out by using standard drug nystatin and compounds 4, 5, 9, 11 and compound 12 was found to be active against C. albicans. Compounds 4, 5, 9 and compound 10 showed good activities while 7, 11, and compound 13 showed excellent activities against Chrysosporium sp. Compounds 6, 7 and compound 12 were found to be most active against A. Niger and A. flavus, respectively. Conclusion: A number of derivatives were identified to have potent antimicrobial activities and may serve as lead compounds for future research.
Benzo five-membered heterocyclic IDO1 (indoleamine 2,3-dioxygenase 1) inhibitor, preparation method thereof and application
-
Paragraph 0169; 0170; 0171; 0172; 0173; 0174; 0175; 0176, (2017/07/22)
The invention belongs to the field of medicines, and particularly relates to a benzo five-membered heterocyclic compound or pharmaceutically acceptable salt of the compound, a preparation method of the compound and an application of the compound serving as an IDO1 (indoleamine 2,3-dioxygenase 1) inhibitor. Experimental results indicate that the compound has a remarkable inhibiting effect on activity of IDO1, T cell proliferation can be effectively promoted, differentiation of initial T cells into regulatory T cells is inhibited, IDO1-mediated immune inhibition is reversed, and the compound can be used for treating related diseases with pathological features of an IDO1-mediated kynurenine metabolic pathway, wherein the related diseases include cancer, virus infection, neurodegenerative diseases, cataract, organ transplant rejection, depression and autoimmune diseases.
